Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$2.82 - $12.9 $2,134 - $9,765
-757 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$4.33 - $11.64 $28,145 - $75,660
-6,500 Reduced 89.57%
757 $8,000
Q2 2019

Aug 12, 2019

BUY
$4.6 - $10.13 $33,382 - $73,513
7,257 New
7,257 $42,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $61M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.